Characterization of street rabies virus variants with an additional N-glycan at position 247 in the glycoprotein

Archives of Virology

Volumn 159, Issue 2, 2014, Pages 207-216

  Yamada, Kentaro ^a   Noguchi, Kazuko ^a   Nishizono, Akira ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN G, RABIES VIRUS; POLYSACCHARIDE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL; ARTICLE; CELL LINE; CHEMISTRY; DISEASE MODEL; DNA SEQUENCE; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MISSENSE MUTATION; MOLECULAR CLONING; MOUSE; NERVE CELL; PATHOGENICITY; PATHOLOGY; RABIES; RABIES VIRUS; VIROLOGY; VIRULENCE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; FEMALE; GLYCOPROTEINS; HUMANS; MICE; MUTATION, MISSENSE; NEURONS; POLYSACCHARIDES; RABIES; RABIES VIRUS; SEQUENCE ANALYSIS, DNA; VIRAL ENVELOPE PROTEINS; VIRULENCE; VIRUS REPLICATION;

EID: 84895073852     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-013-1805-5     Document Type: Article

References (38)

1. Wunner WH (2007) Rabies virus. In: Jackson AC, Wunner WH (eds) Rabies, 2nd edn. Academic Press, San Diego, pp 23-68.
2. Wiktor TJ, Gyorgy E, Schlumberger D, Sokol F, Koprowski H (1973) Antigenic properties of rabies virus components. J Immunol 110(1): 269-276.
3. Dietzschold B, Wiktor TJ, Trojanowski JQ, Macfarlan RI, Wunner WH, Torres-Anjel MJ, Koprowski H (1985) Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J Virol 56(1): 12-18.
4. Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H (1983) Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80(1): 70-74.
5. Etessami R, Conzelmann KK, Fadai-Ghotbi B, Natelson B, Tsiang H, Ceccaldi PE (2000) Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study. J Gen Virol 81(9): 2147-2153.
6. Ito N, Takayama M, Yamada K, Sugiyama M, Minamoto N (2001) Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice. J Virol 75(19): 9121-9128.
7. Morimoto K, Foley HD, McGettigan JP, Schnell MJ, Dietzschold B (2000) Reinvestigation of the role of the rabies virus glycoprotein in viral pathogenesis using a reverse genetics approach. J Neurovirol 6(5): 373-381.
8. Morimoto K, Hooper DC, Spitsin S, Koprowski H, Dietzschold B (1999) Pathogenicity of different rabies virus variants inversely correlates with apoptosis and rabies virus glycoprotein expression in infected primary neuron cultures. J Virol 73(1): 510-518.
9. Seif I, Coulon P, Rollin PE, Flamand A (1985) Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol 53(3): 926-934.
10. Tuffereau C, Leblois H, Benejean J, Coulon P, Lafay F, Flamand A (1989) Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology 172(1): 206-212.
11. Takayama-Ito M, Inoue K, Shoji Y, Inoue S, Iijima T, Sakai T, Kurane I, Morimoto K (2006) A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein. Virus Res 119(2): 208-215.
12. Takayama-Ito M, Ito N, Yamada K, Sugiyama M, Minamoto N (2006) Multiple amino acids in the glycoprotein of rabies virus are responsible for pathogenicity in adult mice. Virus Res 115(2): 169-175.
13. Takayama-Ito M, Ito N, Yamada K, Minamoto N, Sugiyama M (2004) Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice. J Neurovirol 10(2): 131-135.
14. Yamada K, Park CH, Noguchi K, Kojima D, Kubo T, Komiya N, Matsumoto T, Mitui MT, Ahmed K, Morimoto K, Inoue S, Nishizono A (2012) Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus. Virus Res 165(1): 34-45.
15. Yamada K, Noguchi K, Nonaka D, Morita M, Yasuda A, Kawazato H, Nishizono A (2013) Addition of a single N-glycan to street rabies virus glycoprotein enhances virus production. J Gen Virol 94(2): 270-275.
16. Ito N, Takayama-Ito M, Yamada K, Hosokawa J, Sugiyama M, Minamoto N (2003) Improved recovery of rabies virus from cloned cDNA using a vaccinia virus-free reverse genetics system. Microbiol Immunol 47(8): 613-617.
17. Mifune K, Makino Y, Mannen K (1979) Susceptibility of various cell lines to rabies virus. Japan J Trop Med Hyg 7(3): 201-208.
18. Luo TR, Minamoto N, Ito H, Goto H, Hiraga S, Ito N, Sugiyama M, Kinjo T (1997) A virus-neutralizing epitope on the glycoprotein of rabies virus that contains Trp251 is a linear epitope. Virus Res 51(1): 35-41.
19. Hiramatsu K, Mifune K, Mannen K, Nishizono A, Kawano H, Ito Y, Kawai A (1992) Mapping of the antigenic determinants recognized by monoclonal antibodies against the M2 protein of rabies virus. Virology 187(2): 472-479.
20. Smith JS, Yager PA, Baer GM (1973) A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 48(5): 535-541.
21. Shiota S, Mannen K, Matsumoto T, Yamada K, Yasui T, Takayama K, Kobayashi Y, Khawplod P, Gotoh K, Ahmed K, Iha H, Nishizono A (2009) Development and evaluation of a rapid neutralizing antibody test for rabies. J Virol Methods 161(1): 58-62.
22. Phares TW, Kean RB, Mikheeva T, Hooper DC (2006) Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 176(12): 7666-7675.
23. Kuang Y, Lackay SN, Zhao L, Fu ZF (2009) Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection. Virus Res 144(1-2): 18-26.
24. Hooper DC, Phares TW, Fabis MJ, Roy A (2009) The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system. PLoS Negl Trop Dis 3(10): e535.
25. Roy A, Hooper DC (2008) Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity. J Neurovirol 14(5): 401-411.
26. Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC (2008) Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc Natl Acad Sci USA 105(40): 15511-15516.
27. Roy A, Phares TW, Koprowski H, Hooper DC (2007) Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection. J Virol 81(3): 1110-1118.
28. Roy A, Hooper DC (2007) Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol 81(15): 7993-7998.
29. Phares TW, Fabis MJ, Brimer CM, Kean RB, Hooper DC (2007) A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J Immunol 178(11): 7334-7343.
30. Faber M, Faber ML, Papaneri A, Bette M, Weihe E, Dietzschold B, Schnell MJ (2005) A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J Virol 79(22): 14141-14148.
31. Liu Y, Zhang S, Zhang F, Hu R (2012) Adaptation of a Chinese ferret badger strain of rabies virus to high-titered growth in BHK-21 cells for canine vaccine development. Arch Virol 157(12): 2397-2403.
32. Prehaud C, Coulon P, LaFay F, Thiers C, Flamand A (1988) Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J Virol 62(1): 1-7.
33. Tao L, Ge J, Wang X, Zhai H, Hua T, Zhao B, Kong D, Yang C, Chen H, Bu Z (2010) Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation. J Virol 84(17): 8926-8936.
34. Faber M, Pulmanausahakul R, Nagao K, Prosniak M, Rice AB, Koprowski H, Schnell MJ, Dietzschold B (2004) Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc Natl Acad Sci USA 101(46): 16328-16332.
35. Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, Tseggai T, Jiang B, Fu ZF (2005) Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system. J Virol 79(19): 12554-12565.
36. Prehaud C, Wolff N, Terrien E, Lafage M, Megret F, Babault N, Cordier F, Tan GS, Maitrepierre E, Menager P, Chopy D, Hoos S, England P, Delepierre M, Schnell MJ, Buc H, Lafon M (2010) Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein. Science Signal 3 (105): ra5.
37. Mebatsion T, Weiland F, Conzelmann KK (1999) Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G. J Virol 73(1): 242-250.
38. Nakahara K, Ohnuma H, Sugita S, Yasuoka K, Nakahara T, Tochikura TS, Kawai A (1999) Intracellular behavior of rabies virus matrix protein (M) is determined by the viral glycoprotein (G). Microbiol Immunol 43(3): 259-270.